Jefferies Starts NGM Biopharmaceuticals (NGM) at Buy
Tweet
Share
E-mailGet Alerts NGM Hot Sheet
Price: $5.16 -4.27%
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 29
Rating Summary:
7 Buy, 3 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 28 | New: 29
Join SI Premium – FREE
Jefferies analyst Dennis Ding initiates coverage on NGM Biopharmaceuticals (NASDAQ: NGM) with a Buy rating and a price target of $25.00.
For an analyst ratings summary and ratings history on NGM Biopharmaceuticals click here. For more ratings news on NGM Biopharmaceuticals click here.
Shares of NGM Biopharmaceuticals closed at $16.03 yesterday.
You May Also Be Interested In
- Walmart (WMT) started at Overweight at Barclays on defensive characteristics
- Barclays Starts Driven Brands (DRVN) at Overweight
- Raymond James Starts Brighthouse Financial, Inc. (BHF) at Market Perform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
